Stock listing

Intellia Therapeutics, Inc.

Selected listing: NTLA · NASDAQ · USD · US

Intellia Therapeutics, Inc. (NASDAQ:NTLA), Health Technology. Latest release Oct 2, 2026: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing…

NTLA:NASDAQUSDUSUpdated October 2, 2026
Intellia Therapeutics, Inc. logo
Ticker
NASDAQ:NTLA
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

About Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative gene editing therapies. Intellia is dedicated to advancing its research and development efforts in the field of genetic medicine.

Latest news from Intellia Therapeutics, Inc.

All Intellia Therapeutics, Inc. news →

Events

Replays

  • Intellia Therapeutics, Inc. (NTLA) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 08:00 AM ET

    Watch
  • Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 08:00 AM ET

    Watch
  • Intellia Therapeutics, Inc. (NTLA) Q3 2025 Earnings Call

    Thu, Nov 06, 2025 · 06:00 PM ET

    Watch

Research Intellia Therapeutics, Inc.

Alternate listings